News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive April 9, 2024 Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum Archive February 27, 2024 Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences Archive February 6, 2024 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results Archive February 1, 2024 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024 Archive February 1, 2024 Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference Archive January 18, 2024 Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium Archive January 8, 2024 Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company Archive January 5, 2024 Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18 Archive January 2, 2024 Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference Archive November 29, 2023 Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
Archive April 9, 2024 Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Archive February 6, 2024 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2023 Financial Results
Archive February 1, 2024 Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call and Webcast on February 6, 2024
Archive February 1, 2024 Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Archive January 18, 2024 Deciphera Pharmaceuticals Presents Long-Term Follow-Up Results from INTRIGUE Phase 3 Clinical Study in Second-Line GIST Patients at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Archive January 8, 2024 Deciphera Pharmaceuticals Announces Planned 2024 Corporate Milestones Supporting Evolution to a Self-Sustaining, Multi-Product Company
Archive January 5, 2024 Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIST Patients with Mutations in KIT Exon 11 and 17/18
Archive January 2, 2024 Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Archive November 29, 2023 Deciphera Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
